Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Co-stimulatory and Co-inhibitory Pathways in Autoimmunity.
ERβ in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity.
25 Hydroxyvitamin D and Cytokines in Multiple Sclerosis.
Information processing speed in multiple sclerosis: Past, present, and future.
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis.
Cost-Effectiveness of Subcutaneous Interferon Beta-1A in a Sub-Population of Multiple Sclerosis Patients (Kurtzke Expanded Disability Status Scale [EDSS]: >3.5-5.0).
Mucocele After Orbital Fracture Repair Masquerading as Optic Neuritis.
Improving Clinical Outcomes and Health Care Resources Utilization in Multiple Sclerosis: A Portuguese Hospital Perspective.
The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.
Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study.
Difficulties in adjustment to multiple sclerosis: vulnerability and unpredictability of illness in the foreground.
All relapsing multiple sclerosis patients should be managed at a specialist clinic - YES.
Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study.
An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study.
Optic neuritis as a presenting symptom of Mycoplasma pneumoniae infection.
Systematic Review and Critique of Health Economic Models on Relapsing-Remitting Multiple Sclerosis in the UK.
A fatal mycotic sepsis after retrograde intrarenal surgery: a case report and literature review.
Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod.
Using a Panel Survey to Identify Predictors of Disease-Modifying Drug Adherence in Patients with Multiple Sclerosis.
Working Ability and Monetarily Valued Productivity of Patients with Multiple Sclerosis Treated with Natalizumab.
The Impact of Adherence and Development of Neutralizing Antibodies to Interferons β on Treatment of Multiple Sclerosis in the Czech Republic.
Expected Value of Partial Perfect Information for the Disability Progression Efficacy of Teriflunomide and Fingolimod in the Treatment of Relapsing-Remitting Multiple Sclerosis.
Chronic pain disrupts the reward circuitry in multiple sclerosis.
Quantitative Susceptibility Mapping Indicates a Disturbed Brain Iron Homeostasis in Neuromyelitis Optica - A Pilot Study.
Co-occurrence of multiple sclerosis and Parkinson disease.

Pages